Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia.
The effect of bromocriptine on chronic nonfluent aphasia was investigated in 4 patients suffering from a stroke 24 to 35 months before the onset of this study (average 29 months). Two patients had Broca, one had global and the other transcortical motor aphasia. CT-scans demonstrated anterior-posterior infarctions in 3 patients and anterior infarction in one. Bromocriptine was given initially at a dosage of 10 mg/day, and of 25 mg/day during the follow ups. By means of aphasia tests, bromocriptine was found to be ineffective for the treatment of any symptoms of chronic nonfluent aphasia.
Ozeren
A
A
Department of Neurology, School of Medicine, Cukurova University, Balcali, Adana, Turkey.
Sarica
Y
Y
Mavi
H
H
Demirkiran
M
M
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001039:Aphasia, Broca / Q000188:drug therapy*; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017211:Treatment Failure
D000978:Antiparkinson Agents; D001971:Bromocriptine